Clinical Trial Update: Gemtuzumab Ozogamicin Before Allogeneic Stem Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating gemtuzumab ozogamicin given before allogeneic stem cell transplantation in patients with acute myeloid leukemia; cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Mylotarg (gemtuzumab ozogamicin)

Snippet

Sponsor: University Hospital Carl Gustav Carus | Conditions: Acute Myeloid Leukemia, Allogeneic Transplantation | Phase 1, Phase 2 | Status: UNKNOWN